Skip to Content

Bunavail Approval History

FDA Approved: Yes (First approved June 6, 2014)
Brand name: Bunavail
Generic name: buprenorphine and naloxone
Dosage form: Buccal Film
Company: BioDelivery Sciences International, Inc.
Treatment for: Opiate Dependence

Bunavail (buprenorphine and naloxone) buccal film is an opioid analgesic/opioid antagonist formulation for the maintenance treatment of opioid dependence.

Development History and FDA Approval Process for Bunavail

DateArticle
Jun  9, 2014Approval FDA Approves Bunavail Buccal Film for the Maintenance Treatment of Opioid Dependence
Oct 14, 2013BioDelivery Sciences Announces FDA Acceptance of Bunavail NDA for Filing

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide